Transcriptomics

Dataset Information

0

Dual antagonism of the endothelin A and angiotensin II type 1 receptors protects from glomerular hypercellularity in a model of IgA nephropathy


ABSTRACT: IgA nephropathy (IgAN), the most common primary glomerulonephritis worldwide, is characterized by glomerular deposition of immune complexes (IC) consisting of IgA1 with some O-glycans deficient in galactose (Gd-IgA1) and Gd-IgA1-specific IgG autoantibodies. These IC induce kidney injury, and in the absence of disease-specific therapy, up to 40% of IgAN patients progress to kidney failure. IgA1 with its clustered O-glycans is unique to humans, which hampered development of small-animal models of IgAN. To address this issue, we developed a model wherein engineered IC (EIC) formed from human Gd-IgA1 and recombinant IgG autoantibody are injected into nude mice to induce glomerular injury mimicking human IgAN. Here, we used this animal model to assess the protective effects of sparsentan, a single-molecule dual antagonist of endothelin A receptor (ETAR) and angiotensin II type 1 receptor (AT1R) (DEARA). Oral administration of sparsentan (60 or 120 mg/kg) to mice intravenously injected with EIC attenuated the EIC-induced glomerular hypercellularity.

ORGANISM(S): Mus musculus

PROVIDER: GSE225447 | GEO | 2024/02/29

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2021-01-31 | GSE156179 | GEO
2017-02-17 | ST000560 | MetabolomicsWorkbench
2020-10-07 | GSE159123 | GEO
2023-02-20 | GSE145652 | GEO
2017-07-03 | E-GEOD-93798 | biostudies-arrayexpress
2017-07-03 | GSE93798 | GEO
2023-10-19 | GSE242721 | GEO
2015-05-18 | E-GEOD-50469 | biostudies-arrayexpress
2012-03-12 | GSE25590 | GEO
2022-10-14 | GSE215272 | GEO